SCHEMBL15435977

SCHEMBL15435977

c1ccc(-n2c3ccccc3c3ccc(-c4cccc5c4c4ccccc4n5-c4cccc(-n5c6ccccc6c6ccccc65)c4)cc32)cc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ L3MBTL1 Q9Y468 2/20 0.51
▸ KDM4E B2RXH2 1/20 0.51
▸ ATM Q13315 1/20 0.51
▸ HDAC4 P56524 1/20 0.37
▸ KMT2A Q03164 4/20 0.35
▸ IL1R1 P14778 1/20 0.35
▸ ALDH1A1 P00352 4/20 0.34
▸ MEN1 O00255 3/20 0.34
▸ MAPT P10636 1/20 0.34
▸ HTT P42858 1/20 0.34
▸ JAK2 O60674 1/20 0.33
▸ JAK3 P52333 1/20 0.33
▸ POLB P06746 1/20 0.33
▸ TSHR P16473 1/20 0.33
▸ BRCA1 P38398 1/20 0.33
▸ HSD17B10 Q99714 1/20 0.33
▸ MAPK14 Q16539 1/20 0.33
▸ RXFP1 Q9HBX9 1/20 0.32
▸ MAPK8 P45983 1/20 0.32
▸ GAA P10253 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26788611 1.00 L3MBTL1 (0.51) L3MBTL1KDM4EATMHDAC4KMT2A
SCHEMBL29742923 0.97 L3MBTL1 (0.55) L3MBTL1KDM4EATMHDAC4KMT2A
SCHEMBL16665983 0.97 L3MBTL1 (0.55) L3MBTL1KDM4EATMHDAC4KMT2A
SCHEMBL26788609 0.96 L3MBTL1 (0.53) L3MBTL1KDM4EATMHDAC4KMT2A
SCHEMBL26788533 0.96 L3MBTL1 (0.53) L3MBTL1KDM4EATMHDAC4KMT2A
SCHEMBL26788545 0.94 L3MBTL1 (0.49) L3MBTL1KDM4EATMHDAC4KMT2A
SCHEMBL26788542 0.94 L3MBTL1 (0.51) L3MBTL1KDM4EATMHDAC4KMT2A
SCHEMBL26788440 0.94 L3MBTL1 (0.51) L3MBTL1KDM4EATMHDAC4KMT2A
SCHEMBL26788503 0.94 L3MBTL1 (0.51) L3MBTL1KDM4EATMHDAC4KMT2A
SCHEMBL26788441 0.94 L3MBTL1 (0.51) L3MBTL1KDM4EATMHDAC4KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12029120-B2 Organic electroluminescence element and electronic device IDEMITSU KOSAN CO., LTD. (JP) 2024-07-02 — — US disclosed
US-20230371373-A1 ORGANIC ELECTROLUMINESCENT ELEMENT, COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE ldemitsu Kosan Co.,Ltd. (JP) 2023-11-16 — — US disclosed
US-20230371373-A1 ORGANIC ELECTROLUMINESCENT ELEMENT, COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE ldemitsu Kosan Co.,Ltd. (JP) 2023-11-16 — — US disclosed
EP-2688120-B1 LIGHT-EMITTING ELEMENT MATERIAL AND LIGHT-EMITTING ELEMENT TORAY INDUSTRIES (JP) 2017-08-23 — — EP disclosed
US-9537107-B2 Light emitting device material and light emitting device TORAY INDUSTRIES, INC. (JP) 2017-01-03 — — US disclosed
EP-2688120-A1 LIGHT-EMITTING ELEMENT MATERIAL AND LIGHT-EMITTING ELEMENT Toray Industries, Inc. (JP) 2014-01-22 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12029120-B2 Organic electroluminescence element and electronic device RPS10, H1-10, OR10J3 L3MBTL1 679/4885KDM4E 1340/4885ATM 3092/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback